Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease
Open Access
- 4 August 2022
- journal article
- review article
- Published by Springer Nature in Archives of Toxicology
- Vol. 96 (11) , 2881-2897
Abstract
Adverse outcome pathways (AOPs), introduced in modern toxicology, intend to provide an evidence-based representation of toxicological effects and facilitate safety assessment of chemicals not solely based on laboratory animal in vivo experiments. However, some toxicological processes are too complicated to represent in one AOP. Therefore, AOP networks are developed that help understanding and predicting toxicological processes where complex exposure scenarios interact and lead to the emergence of the adverse outcome. In this study, we present an AOP network for breast cancer, developed after an in-depth survey of relevant scientific literature. Several molecular initiating events (MIE) were identified and various key events that link the MIEs with breast cancer were described. The AOP was developed according to Organization of Economic Co-Operation and Development (OECD) guidance, weight of evidence was assessed through the Bradford Hill criteria and confidence was tested by the OECD key questions. The AOP network provides a straightforward understanding of the disease onset and progression at different biological levels. It can be used to pinpoint knowledge gaps, identify novel therapeutic targets and act as a stepping stone for the development of novel in vitro test methods for hazard identification and risk assessment of newly developed chemicals and drugs.Keywords
This publication has 74 references indexed in Scilit:
- Oxidative stress and cancer: An overviewAgeing Research Reviews, 2013
- Aromatase, breast cancer and obesity: a complex interactionTrends in Endocrinology & Metabolism, 2012
- A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer CellsCell, 2011
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunitiesJournal of Cellular Biochemistry, 2008
- The epidermal growth factor receptor family: Biology driving targeted therapeuticsCellular and Molecular Life Sciences, 2008
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisOncogene, 2007
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000